Early surgery plus steroid for brain bleeds
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a procedure that uses a small camera to remove the blood clot from the brain, combined with a steroid medication, to reduce damage from a brain bleed. It may be an option for people with a moderate-to-large brain bleed in the outer part of the brain who can be treated within 24 hours.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old.
- You have a bleed in the outer part of the brain (lobar region) that is between 30 and 80 ml in size.
- You have a stroke severity score (NIHSS) of 6 or more.
- Your Glasgow Coma Scale score is between 5 and 14.
- You can start treatment within 24 hours of symptoms starting.
- You are not on blood thinners that would interfere with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination approach—using a scope through a small skull opening to remove the clot from a deep brain bleed (basal ganglia), then giving a steroid called methylprednisolone to reduce inflammation. It may help people with a moderate-sized bleed who get treated within 24 hours.
This trial tests whether removing a certain type of brain bleed (intracerebral hemorrhage) very early, using a minimally invasive surgery approach, improves outcomes compared with standard treatment. It may help people whose bleed is large enough and who can have surgery within a strict time window.
This trial tests if surgery to remove a large brain bleed (called lobar ICH) can help patients recover. It's for people who can have surgery within 16 hours of symptoms starting.
This trial tests a minimally invasive procedure using a special clot-busting medicine (tenecteplase) for a certain type of brain bleed. It aims to see if this approach improves recovery compared to standard care.
This trial tests whether a drug called cerebrolysin can help people who have a bleeding stroke in the outer part of the brain (lobar hemorrhage). It looks at safety and how well it works.
This trial tests a type of keyhole surgery called neuroendoscopic surgery to remove large blood clots in the brain. It may help people who have had a serious brain bleed and need urgent surgery.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.